Keytru­da and Lenvi­ma still have an­oth­er hill to climb fol­low­ing lat­est da­ta drop

BARCELONA — Mer­ck’s bumpy six-year re­la­tion­ship with Ei­sai’s an­ti-can­cer med­ica­tion Lenvi­ma land­ed on some­what bet­ter foot­ing in Spain over the week­end, but the duo is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER